BACKGROUND & AIMS: Insulin and leptin have proliferative and anti-apoptotic effects. Ghrelin promotes gastric emptying and secretion of growth hormone and inhibits inflammation. We assessed whether diabetes mellitus and serum levels of insulin, leptin, and ghrelin are associated with gastroesophageal reflux disease (GERD) and Barrett's esophagus. METHODS: We conducted a case-control study in 822 men undergoing colorectal cancer screening who were recruited to also undergo upper endoscopy. We identified 70 with Barrett's esophagus; 80 additional men with Barrett's esophagus were recruited shortly after their clinical diagnoses. Serum levels of insulin, leptin, and ghrelin were assayed in all 104 fasting men with Barrett's esophagus without diabetes and 271 without diabetes or Barrett's esophagus. Logistic regression was used to estimate the effects of diabetes and levels of insulin, leptin, and ghrelin on GERD and Barrett's esophagus. RESULTS: Among men with GERD, diabetes was inversely associated with Barrett's esophagus (adjusted odds ratio [OR] = 0.383; 95% confidence interval [CI]: 0.179-0.821). Among nondiabetics, hyperinsulinemia was positively associated with Barrett's esophagus, but the association was attenuated by adjustment for leptin and ghrelin. Leptin was positively associated with Barrett's esophagus, adjusting for obesity, GERD, and levels of insulin and ghrelin (OR for 3(rd) vs 1(st) tertile = 3.25; 95% CI: 1.29-8.17); this association was stronger in men with GERD (P = .01 for OR heterogeneity). Ghrelin was positively associated with Barrett's esophagus (OR for an increment of 400 pg/mL = 1.39; 95% CI: 1.09-1.76), but inversely associated with GERD (OR for 3(rd) vs 1(st) tertile = 0.364; 95% CI: 0.195-0.680). CONCLUSIONS: Based on a case-control study, leptin was associated with Barrett's esophagus, particularly in men with GERD. Serum insulin level was associated with Barrett's esophagus, but might be mediated by leptin. Serum ghrelin was inversely associated with GERD, as hypothesized, but positively associated with Barrett's esophagus, contrary to our hypothesis. Additional studies are needed in men and women to replicate these findings.
BACKGROUND & AIMS:Insulin and leptin have proliferative and anti-apoptotic effects. Ghrelin promotes gastric emptying and secretion of growth hormone and inhibits inflammation. We assessed whether diabetes mellitus and serum levels of insulin, leptin, and ghrelin are associated with gastroesophageal reflux disease (GERD) and Barrett's esophagus. METHODS: We conducted a case-control study in 822 men undergoing colorectal cancer screening who were recruited to also undergo upper endoscopy. We identified 70 with Barrett's esophagus; 80 additional men with Barrett's esophagus were recruited shortly after their clinical diagnoses. Serum levels of insulin, leptin, and ghrelin were assayed in all 104 fasting men with Barrett's esophagus without diabetes and 271 without diabetes or Barrett's esophagus. Logistic regression was used to estimate the effects of diabetes and levels of insulin, leptin, and ghrelin on GERD and Barrett's esophagus. RESULTS: Among men with GERD, diabetes was inversely associated with Barrett's esophagus (adjusted odds ratio [OR] = 0.383; 95% confidence interval [CI]: 0.179-0.821). Among nondiabetics, hyperinsulinemia was positively associated with Barrett's esophagus, but the association was attenuated by adjustment for leptin and ghrelin. Leptin was positively associated with Barrett's esophagus, adjusting for obesity, GERD, and levels of insulin and ghrelin (OR for 3(rd) vs 1(st) tertile = 3.25; 95% CI: 1.29-8.17); this association was stronger in men with GERD (P = .01 for OR heterogeneity). Ghrelin was positively associated with Barrett's esophagus (OR for an increment of 400 pg/mL = 1.39; 95% CI: 1.09-1.76), but inversely associated with GERD (OR for 3(rd) vs 1(st) tertile = 0.364; 95% CI: 0.195-0.680). CONCLUSIONS: Based on a case-control study, leptin was associated with Barrett's esophagus, particularly in men with GERD. Serum insulin level was associated with Barrett's esophagus, but might be mediated by leptin. Serum ghrelin was inversely associated with GERD, as hypothesized, but positively associated with Barrett's esophagus, contrary to our hypothesis. Additional studies are needed in men and women to replicate these findings.
Authors: Katarina B Greer; Cheryl L Thompson; Lacie Brenner; Beth Bednarchik; Dawn Dawson; Joseph Willis; William M Grady; Gary W Falk; Gregory S Cooper; Li Li; Amitabh Chak Journal: Gut Date: 2011-09-19 Impact factor: 23.059
Authors: Olivia M Thompson; Shirley A A Beresford; Elizabeth A Kirk; Mary P Bronner; Thomas L Vaughan Journal: Obesity (Silver Spring) Date: 2010-01-28 Impact factor: 5.002
Authors: Mohammad H Derakhshan; Elaine V Robertson; Jonathan Fletcher; Gareth-Rhys Jones; Yeong Yeh Lee; Angela A Wirz; Kenneth E L McColl Journal: Gut Date: 2011-08-28 Impact factor: 23.059
Authors: Gwen Murphy; Farin Kamangar; Demetrius Albanes; Frank Z Stanczyk; Stephanie J Weinstein; Philip R Taylor; Jarmo Virtamo; Christian C Abnet; Sanford M Dawsey; Neal D Freedman Journal: Gut Date: 2011-12-16 Impact factor: 23.059
Authors: Gwen Murphy; Farin Kamangar; Sanford M Dawsey; Frank Z Stanczyk; Stephanie J Weinstein; Philip R Taylor; Jarmo Virtamo; Christian C Abnet; Demetrius Albanes; Neal D Freedman Journal: J Natl Cancer Inst Date: 2011-06-21 Impact factor: 13.506
Authors: Joel H Rubenstein; Hal Morgenstern; Henry Appelman; James Scheiman; Philip Schoenfeld; Laurence F McMahon; Valbona Metko; Ellen Near; Joan Kellenberg; Tal Kalish; John M Inadomi Journal: Am J Gastroenterol Date: 2013-01-15 Impact factor: 10.864
Authors: Joel H Rubenstein; Hal Morgenstern; William D Chey; Joseph Murray; James M Scheiman; Philip Schoenfeld; Henry D Appelman; Laurence McMahon; Val Metko; Joan Kellenberg; Tal Kalish; Jason Baker; John M Inadomi Journal: Gut Date: 2013-03-05 Impact factor: 23.059
Authors: K K Cheng; L Sharp; P A McKinney; R F Logan; C E Chilvers; P Cook-Mozaffari; A Ahmed; N E Day Journal: Br J Cancer Date: 2000-07 Impact factor: 7.640
Authors: Zhan Su; Laura J Gay; Amy Strange; Claire Palles; Gavin Band; David C Whiteman; Francesco Lescai; Cordelia Langford; Manoj Nanji; Sarah Edkins; Anouk van der Winkel; David Levine; Peter Sasieni; Céline Bellenguez; Kimberley Howarth; Colin Freeman; Nigel Trudgill; Art T Tucker; Matti Pirinen; Maikel P Peppelenbosch; Luc J W van der Laan; Ernst J Kuipers; Joost P H Drenth; Wilbert H Peters; John V Reynolds; Dermot P Kelleher; Ross McManus; Heike Grabsch; Hans Prenen; Raf Bisschops; Kausila Krishnadath; Peter D Siersema; Jantine W P M van Baal; Mark Middleton; Russell Petty; Richard Gillies; Nicola Burch; Pradeep Bhandari; Stuart Paterson; Cathryn Edwards; Ian Penman; Kishor Vaidya; Yeng Ang; Iain Murray; Praful Patel; Weimin Ye; Paul Mullins; Anna H Wu; Nigel C Bird; Helen Dallal; Nicholas J Shaheen; Liam J Murray; Konrad Koss; Leslie Bernstein; Yvonne Romero; Laura J Hardie; Rui Zhang; Helen Winter; Douglas A Corley; Simon Panter; Harvey A Risch; Brian J Reid; Ian Sargeant; Marilie D Gammon; Howard Smart; Anjan Dhar; Hugh McMurtry; Haythem Ali; Geoffrey Liu; Alan G Casson; Wong-Ho Chow; Matt Rutter; Ashref Tawil; Danielle Morris; Chuka Nwokolo; Peter Isaacs; Colin Rodgers; Krish Ragunath; Chris MacDonald; Chris Haigh; David Monk; Gareth Davies; Saj Wajed; David Johnston; Michael Gibbons; Sue Cullen; Nicholas Church; Ruth Langley; Michael Griffin; Derek Alderson; Panos Deloukas; Sarah E Hunt; Emma Gray; Serge Dronov; Simon C Potter; Avazeh Tashakkori-Ghanbaria; Mark Anderson; Claire Brooks; Jenefer M Blackwell; Elvira Bramon; Matthew A Brown; Juan P Casas; Aiden Corvin; Audrey Duncanson; Hugh S Markus; Christopher G Mathew; Colin N A Palmer; Robert Plomin; Anna Rautanen; Stephen J Sawcer; Richard C Trembath; Ananth C Viswanathan; Nicholas Wood; Gosia Trynka; Cisca Wijmenga; Jean-Baptiste Cazier; Paul Atherfold; Anna M Nicholson; Nichola L Gellatly; Deborah Glancy; Sheldon C Cooper; David Cunningham; Tore Lind; Julie Hapeshi; David Ferry; Barrie Rathbone; Julia Brown; Sharon Love; Stephen Attwood; Stuart MacGregor; Peter Watson; Scott Sanders; Weronica Ek; Rebecca F Harrison; Paul Moayyedi; John de Caestecker; Hugh Barr; Elia Stupka; Thomas L Vaughan; Leena Peltonen; Chris C A Spencer; Ian Tomlinson; Peter Donnelly; Janusz A Z Jankowski Journal: Nat Genet Date: 2012-09-09 Impact factor: 38.330
Authors: Sarina Pasricha; Nan Li; William J Bulsiewicz; Richard I Rothstein; Anthony Infantolino; Atilla Ertan; Daniel S Camara; Evan S Dellon; George Triadafilopoulos; Charles J Lightdale; Ryan D Madanick; William D Lyday; Raman V Muthusamy; Bergein F Overholt; Nicholas J Shaheen Journal: Gastrointest Endosc Date: 2015-04-01 Impact factor: 9.427
Authors: Stuart J Thomas; Lucy Almers; Jennifer Schneider; James E Graham; Peter J Havel; Douglas A Corley Journal: Dig Dis Sci Date: 2015-09-22 Impact factor: 3.199
Authors: Katarina B Greer; Gary W Falk; Beth Bednarchik; Li Li; Amitabh Chak Journal: Clin Gastroenterol Hepatol Date: 2015-02-28 Impact factor: 11.382
Authors: P Quitadamo; L Zenzeri; E Mozzillo; V Giorgio; A Rocco; A Franzese; G Nardone; A Staiano Journal: J Endocrinol Invest Date: 2020-09-22 Impact factor: 4.256
Authors: Bradley J Kendall; Joel H Rubenstein; Michael B Cook; Thomas L Vaughan; Lesley A Anderson; Liam J Murray; Nicholas J Shaheen; Douglas A Corley; Apoorva K Chandar; Li Li; Katarina B Greer; Amitabh Chak; Hashem B El-Serag; David C Whiteman; Aaron P Thrift Journal: Clin Gastroenterol Hepatol Date: 2016-06-02 Impact factor: 11.382